Ibuprofen (IBU) is a non-steroidal anti-inflammatory drug (NSAID). A clinician wishing to appropriately control more moderate to severe pain may consider a combination of orally administered ibuprofen (IBU) and acetaminophen for pain control. In dentistry, it is commonly recommended to take oral IBU 400 - 800 mg and acetaminophen 325 - 1000 mg to control postoperative pain following third molar extraction(s). This combination can avoid the use of a narcotic prescription for pain control. However, many patients are taking anticoagulants for a variety of medical conditions and are told not to take IBU, fearing an additive effect of IBU with the anticoagulant. This paper addresses the anticoagulant effects of IBU when administered as a single agent and the interactions with orally administered anticoagulant, antiplatelet, or antithrombotic agents. Ibuprofen may be taken by patients taking anticoagulants for 2 - 5 days without significant interaction. Nonetheless, the prudent clinician should ensure the patient is compliant and that alternative pain medications have been considered.
References
[1]
Michels, S.L., Collins, J., Reynolds, M.W., Abramsky, S., Paredes-Diaz, A. and McCarberg, B. (2012) Over-the-Counter Ibuprofen and Risk of Gastrointestinal Bleeding Complications: A Systematic Literature Review. Current Medical Research and Opinion, 28, 89-99. https://doi.org/10.1185/03007995.2011.633990
[2]
Cramer, J.D., Barnett, M.L., Anne, S., Bateman, B.T., Rosenfeld, R.M., Tunkel, D.E., et al. (2020) Nonopioid, Multimodal Analgesia as First-Line Therapy after Otolaryngology Operations: Primer on Nonsteroidal Anti-Inflammatory Drugs (NSAIDs). Otolaryngology-Head and Neck Surgery, 164, 712-719. https://doi.org/10.1177/0194599820947013
[3]
Bailey, E., Worthington, H.V., van Wijk, A., Yates, J.M., Coulthard, P. and Afzal, Z. (2013) Ibuprofen and/or Paracetamol (Acetaminophen) for Pain Relief after Surgical Removal of Lower Wisdom Teeth. Cochrane Database of Systematic Reviews, 2013, CD004624. https://doi.org/10.1002/14651858.cd004624.pub2
[4]
Grosser, T., Ricciotti, E. and FitzGerald, G.A. (2017) The Cardiovascular Pharmacology of Nonsteroidal Anti-Inflammatory Drugs. Trends in Pharmacological Sciences, 38, 733-748. https://doi.org/10.1016/j.tips.2017.05.008
[5]
Davies, N.M. (1998) Clinical Pharmacokinetics of Ibuprofen. The First 30 Years. Clinical Pharmacokinetics, 34, 101-154. https://doi.org/10.2165/00003088-199834020-00002
[6]
British National Formulary (2014) Ibuprofen on Both. British Medical Association, 686-688.
[7]
Tschopp, M. and Reinhart, W.H. (2008) Platelet Aggregation under High Shear Conditions during and after a 28-Day Administration of 100 mg Acetylsalicylic Acid in Healthy Volunteers. Clinical Hemorheology and Microcirculation, 38, 45-50.
[8]
Nakamura, N., Kaida, D., Tomita, Y., Miyata, T., Miyashita, T., Fujita, H., et al. (2021) Risk Factors for Overall Complications and Remote Infection after Gastrectomy in Elderly Gastric Cancer Patients. InVivo, 35, 2917-2921. https://doi.org/10.21873/invivo.12582
[9]
Gong, Y., Zhang, Y.M., Zhu, J.Q., He, S., Dou, L.Z., et al. (2021) Analysis of Risk Factors for Delayed Bleeding after Endoscopic Submucosal Dissection of Gastric Epithelial Neoplasm. Chinese Journal of Oncology, 43, 861-865.
[10]
Enderes, J., Teschke, J., von Websky, M., Manekeller, S., Kalff, J.C. and Glowka, T.R. (2021) Active Smokers Show Ameliorated Delayed Gastric Emptying after Pancreatoduodenectomy. BMC Surgery, 21, Article No. 316. https://doi.org/10.1186/s12893-021-01311-2
[11]
Fouquet, G., Coman, T., Hermine, O. and Côté, F. (2019) Serotonin, Hematopoiesis and Stem Cells. Pharmacological Research, 140, 67-74. https://doi.org/10.1016/j.phrs.2018.08.005
[12]
Kakuta, H., Zheng, X., Oda, H., Harada, S., Sugimoto, Y., Sasaki, K., et al. (2008) Cyclooxygenase-1-Selective Inhibitors Are Attractive Candidates for Analgesics That Do Not Cause Gastric Damage. Design and in Vitro/in Vivo Evaluation of a Benzamide-Type Cyclooxygenase-1 Selective Inhibitor. Journal of Medicinal Chemistry, 51, 2400-2411. https://doi.org/10.1021/jm701191z
[13]
Chen, H. (2018) Role of Thromboxane A2 Signaling in Endothelium-Dependent Contractions of Arteries. Prostaglandins & Other Lipid Mediators, 134, 32-37. https://doi.org/10.1016/j.prostaglandins.2017.11.004
[14]
Rainsford, K.D. (2012) Relation of Analgesic Effects to COX-1 and COX-2 Inhibition (3.3). In: Ibuprofen: Pharmacology, Therapeutics and Side Effects, Springer, 49-57.
[15]
Rao, P. and Knaus, E.E. (2008) Evolution of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Cyclooxygenase (COX) Inhibition and Beyond. JournalofPharmacy&PharmaceuticalSciences, 11, 81-110. https://doi.org/10.18433/j3t886
[16]
Furie, B. and Furie, B.C. (2005) Thrombus Formation in Vivo. JournalofClinicalInvestigation, 115, 3355-3362. https://doi.org/10.1172/jci26987
[17]
Pallister, C.J. and Watson, M.S. (2010) Blood Coagulation: Mechanisms. In: Haematology, Scion Publishing, 334-336.
[18]
Mackman, N., Tilley, R.E. and Key, N.S. (2007) Role of the Extrinsic Pathway of Blood Coagulation in Hemostasis and Thrombosis. Arteriosclerosis, Thrombosis, and Vascular Biology, 27, 1687-1693. https://doi.org/10.1161/atvbaha.107.141911
[19]
Long, A.T., Kenne, E., Jung, R., Fuchs, T.A. and Renné, T. (2015) Contact System Revisited: An Interface between Inflammation, Coagulation, and Innate Immunity. Journal of Thrombosis and Haemostasis, 14, 427-437. https://doi.org/10.1111/jth.13235
Hersh, E.V., Moore, P.A. and Ross, G.L. (2000) Over-the-Counter Analgesics and Antipyretics: A Critical Assessment. Clinical Therapeutics, 22, 500-548. https://doi.org/10.1016/s0149-2918(00)80043-0
[22]
Dionne, R.A. and Cooper, S.A. (1978) Evaluation of Preoperative Ibuprofen for Postoperative Pain after Removal of Third Molars. Oral Surgery, Oral Medicine, Oral Pathology, 45, 851-856. https://doi.org/10.1016/s0030-4220(78)80004-8
[23]
Dionne, R.A., Campbell, R.A., Cooper, S.A., Hall, D.L. and Buckingham, B. (1983) Suppression of Postoperative Pain by Preoperative Administration of Ibuprofen in Comparison to Placebo, Acetaminophen, and Acetaminophen Plus Codeine. The Journal of Clinical Pharmacology, 23, 37-43. https://doi.org/10.1002/j.1552-4604.1983.tb02702.x
[24]
Dionne, R.A. (1986) Suppression of Dental Pain by the Preoperative Administration of Flurbiprofen. The American Journal of Medicine, 80, 41-49. https://doi.org/10.1016/0002-9343(86)90110-5
[25]
Stichtenoth, D.O., Tsikas, D., Gutzki, F.M. and Frölich, J.C. (1996) Effects of Ketoprofen and Ibuprofen on Platelet Aggregation and Prostanoid Formation in Man. European Journal of Clinical Pharmacology, 51, 231-234. https://doi.org/10.1007/s002280050189
[26]
Jackson, D.L., Moore, P.A. and Hargreaves, K.M. (1989) Preoperative Nonsteroidal Anti-Inflammatory Medication for the Prevention of Postoperative Dental Pain. TheJournaloftheAmericanDentalAssociation, 119, 641-647. https://doi.org/10.1016/s0002-8177(89)95018-6
[27]
Wynn, R.L., Meiller, T.F. and Crossley, H.L. (2013) Drug Information Handbook for Dentistry. Lexi-Comp Inc, 711-715.
[28]
Martini, W.Z., Rodriguez, C.M., Deguzman, R., Guerra, J.B., Martin, A.K., Pusateri, A.E., et al. (2016) Dose Responses of Ibuprofen in Vitro on Platelet Aggregation and Coagulation in Human and Pig Blood Samples. Military Medicine, 181, 111-116. https://doi.org/10.7205/milmed-d-15-00381
[29]
McElwee, N.E., Veltri, J.C., Bradford, D.C. and Rollins, D.E. (1990) A Prospective, Population-Based Study of Acute Ibuprofen Overdose: Complications Are Rare and Routine Serum Levels Not Warranted. Annals of Emergency Medicine, 19, 657-662. https://doi.org/10.1016/s0196-0644(05)82471-0
[30]
Schulman, S. and Henriksson, K. (1989) Interaction of Ibuprofen and Warfarin on Primary Haemostasis. Rheumatology, 28, 46-49. https://doi.org/10.1093/rheumatology/28.1.46
[31]
U.S. Food and Drug Administration (2006) Information for Healthcare Professionals: Concomitant Use of Ibuprofen and Aspirin.
[32]
Shibata, K., Akagi, Y., Nozawa, N., Shimomura, H. and Aoyama, T. (2017) Influence of Nonsteroidal Anti-Inflammatory Drugs on Aspirin’s Antiplatelet Effects and Suggestion of the Most Suitable Time for Administration of Both Agents without Resulting in Interaction. JournalofPharmaceuticalHealthCareandSciences, 3, Article No. 9. https://doi.org/10.1186/s40780-017-0078-7
[33]
Ageno, W., Gallus, A.S., Wittkowsky, A., Crowther, M., et al. (2012) Oral Anticoagulant Therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 141, e44S-e88S.
[34]
Gulløv, A.L., Koefoed, B.G. and Petersen, P. (1999) Bleeding during Warfarin and Aspirin Therapy in Patients with Atrial Fibrillation: The AFASAK 2 Study. Atrial Fibrillation Aspirin and Anticoagulation. Archives of Internal Medicine, 159, 1322-1328.
[35]
Garcia, D.A., Regan, S., Henault, L.E., Upadhyay, A., et al. (2008) Risk of Thromboembolism with Short-Term Interruption of Warfarin Therapy. ArchivesofInternalMedicine, 168, 63-69. https://doi.org/10.1001/archinternmed.2007.23
[36]
Sancilio, L.F., Taylor, M.A., Mathur, P.P. and Crowe, J.T. (1985) Interaction between Warfarin and Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Rats. Life Sciences, 36, 1041-1050. https://doi.org/10.1016/0024-3205(85)90489-8
[37]
Dentali, F., Douketis, J.D., Woods, K., Thabane, L., Foster, G., Holbrook, A., et al. (2006) Does Celecoxib Potentiate the Anticoagulant Effect of Warfarin? A Randomized, Double-Blind, Controlled Trial. Annals of Pharmacotherapy, 40, 1241-1247. https://doi.org/10.1345/aph.1g733
[38]
Tai, W.A. (2022) Stroke: Primary Prevention. FP Essent, 512, 11-17.
[39]
Peacock, W.F., Rafique, Z. and Singer, A.J. (2016) Direct-Acting Oral Anticoagulants: Practical Considerations for Emergency Medicine Physicians. Emergency Medicine International, 2016, 1-13. https://doi.org/10.1155/2016/1781684
[40]
Bassand, J.P. (2014) Novel Oral Anticoagulants in Acute Coronary Syndrome: Re-Evaluating the Thrombin Hypothesis. EuroIntervention, 9, 1333-1341. https://doi.org/10.4244/eijv9i11a224
[41]
Tarn, D.M., Barrientos, M., Wang, A.Y., Ramaprasad, A., Fang, M.C. and Schwartz, J.B. (2020) Prevalence and Knowledge of Potential Interactions between Over-the-Counter Products and Apixaban. Journal of the American Geriatrics Society, 68, 155-162. https://doi.org/10.1111/jgs.16193
[42]
Hersh, E.V., Pinto, A. and Moore, P.A. (2007) Adverse Drug Interactions Involving Common Prescription and Over-the-Counter Analgesic Agents. Clinical Therapeutics, 29, 2477-2497. https://doi.org/10.1016/j.clinthera.2007.12.003
[43]
Lu, Y., Shen, D., Pietsch, M., Nagar, C., Fadli, Z., Huang, H., et al. (2015) A Novel Algorithm for Analyzing Drug-Drug Interactions from MEDLINE Literature. Scientific Reports, 5, Article No. 17357. https://doi.org/10.1038/srep17357
[44]
Kent, A.P. (2020) Navigating NSAID Use in Patients Receiving Oral Anticoagulation: Is There a Safe Course? Thrombosis and Haemostasis, 120, 1001-1003. https://doi.org/10.1055/s-0040-1713098
[45]
Frazee, L.A. and Reed, M.D. (1995) Warfarin and Nonsteroidal Anti-Inflammatory Drugs: Why Not? Annals of Pharmacotherapy, 29, 1289-1291. https://doi.org/10.1177/106002809502901218
[46]
Davidson, B.L., Verheijen, S., Lensing, A.W.A., Gebel, M., Brighton, T.A., Lyons, R.M., et al. (2014) Bleeding Risk of Patients with Acute Venous Thromboembolism Taking Nonsteroidal Anti-Inflammatory Drugs or Aspirin. JAMA Internal Medicine, 174, 947-953. https://doi.org/10.1001/jamainternmed.2014.946
[47]
Ghosh, S., Lahens, N., Barekat, K., Tang, S.Y., et al. (2024) Metabolomic Response to Non-Steroidal Anti-Inflammatory Drugs.
[48]
Lai, J.H., Chang, L., Lin, S., Mo, S., Liu, H. and Qin, J. (2026) Letter to the Editor: “Incidence of Kidney Toxicity of Non-Steroidal Anti-Inflammatory Drugs in Critically Ill Patients”. Journal of Critical Care, 91, Article 155319. https://doi.org/10.1016/j.jcrc.2025.155319
[49]
Abdallah, N.A., Elmansi, H., Alossaimi, M.A., Altamimi, A.S.A., El Abass, S.A. and Elama, H.S. (2026) Harmonizing Drug Analysis and Sustainability: Spectroscopic Quantification of Antiplatelet-Anticoagulant Regimens. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 345, Article 126769. https://doi.org/10.1016/j.saa.2025.126769
[50]
Petersen, S.R., Bonnesen, K., Larsen, J.B., Pedersen, L. and Schmidt, M. (2025) Bleeding Risk Using Non-Steroidal Anti-Inflammatory Drugs in Anticoagulated Patients with Atrial Fibrillation: A Nationwide Cohort Study. European Heart Journal—Quality of Care and Clinical Outcomes, 11, 1340-1350. https://doi.org/10.1093/ehjqcco/qcaf076
